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1997-871 ELISA Tltres of Antl-a Myosin Antibodies In
Idiopathic Dilated Cardiomyopathy Patients
Reduce with Disease Progression
1997-891 Effect of Local Angiotensin II Inhibition on Pattern
of Ventricular Hypertrophy and Characteristics of
Myocardium
Jonathan H. Goldman, Rahat S. Warraich, Philip J. Keeling, Simon Redwood, L.
Dalla Libera 1, Perry Elliott, Alida L.P Calorio 1, William J. McKenna. St George's
Hospital Medical School, UK; 1 Dept Cardiology; University of Padua, Italy
Immunofluorescence detects anti-heart antibodies directed against a range
of cardiac antigens in 30% of patients with idiopathic dilated cardiomyopathy
(OCM), but is not antigen specific, Western blots showed that these antibod-
ies recognise both a (organ specific, atrial) and fJ (cross reactive ventricular
and skeletal) myosin but this technique is nonquantitative and unsuitable for
screening purposes, To assess the frequency and titre of the anti-a myosin
antibodies, we developed a biotin-streptavidin ELISA for detection of IgG to
purified human atrial myosin. A pilot study of 40 OCM patients and 40 IHO
controls revealed 94% concordance between ELISA and Western Blot. Stud-
ies were performed on sera (dilution 1/320) from 123 consecutive patients
with OCM (WHO criteria) presenting to our hospital (age 42 ± 14). These
were compared with sera from 52 normals (45 ± 16) and 58 patients with
ischaemic heart disease (IHO) (65 ± 12), (40% had poor LV function, 65%
had previous MI). Raised antibody levels to atrial myosin were found in 24
(20%) of OCM patients, 1 (2%1 normal control and 3 (5%) of the IHO pa-
tients (OCM v. IHO p < 0.05, IHO v. normal p = 0.4). Mean antibody level ±
SEM in OCM patients were greater than IHO patients (0.27 ± 0.02 v. 0.20 ±
0.01; P = 0.001) but IHO did not differ from normals (0.20 ± 0.01 v. 0.18 ±
0.01; P > 0.1 I. Repeat evaluation on 57 OCM patients after 20 ± 20 months
showed significant reduction in antibody level from 0.3 ± 0.02 to 0.23 ± 0.01
(p = 0.04). In conclusion we confirm the presence of disease specific anti-a
myosin antibodies in OCM patients and show a reduction in antibody level
over time as in other autoimmune diseases.
1997-881 Ventricular Remodeling During Pacing Induced
Congestive Heart Failure: The Logarithmic Model
of Passive Properties is Physiologically and
Mathematically Superior to the Exponential
Model!
Masakazu Obayashi, Michihiro Kohno, Masahumi Yano, Shigeki Kobayashi,
Tsutomu Ryouke, Tomoko Ohkusa, Masunori Matsuzaki. Yamaguchi University
School of Medicine, Ube, Japan
The purpose of this study was to examine the effect of local angiotensin II
IATIII inhibition on amount and pattern of pressure overload-induced ventric-
ular hypertrophy and functional characteristics of myocardium. We adminis-
tered abdominal aorta-constricted rats vehicle (C), 0,3 mglkg/day (low dose;
LO), and 3.0 mg/kg/day (high dose;HOI of ATII receptor antagonist TCV-116.
After 4 weeks treatment, we measured LV pressure using micromanometer
and wall thickness using 20 MHz ultrasonic wall tracker for calculating LV
dimension (01 and midwall fiber stress (FS),
C(n ~ 7) LD In ~ 9) HDln ~ 10)
Peak LVP (mmHg) 165 ± 10 141 ± 9* 137 ± 12*
LV weight (mg/gBW) 289 ± 003 2.40 ± 0.26* 205 ± 0.20*#
end-diastolic WT Imm) 3.7 ± 0.2 3.0 ± 0.3* 30± 0.2*
end-diastolic D(mm) 3.8 ± 0.6 46±Or 3.9 ± 05#
cell Width II-' m) 16.3 ± 0.6 136 ± 0.3* 13.4 ± 0.6*
peak FS (xl03dyn/cm2) 80 ± 8 86±17 69 ± 8#
k -4.9 -4.9 -8.5
*p < 0.01 vs C, # P < 0.01 vs LD k; the slope of regression line between %shortening of
LVD IY-axls) and peak FS IX-axis)
In LO ofTCV-116, WT and cell width significantly decreased compared with
C in spite of the tendency to increase in peak FS. On the other hand, HO of
TCV-116 could inhibit not only development of cell width but also LV dilata-
tion, accompanied with significant reduction of FS. Peak(+ )dP/dt of LVP and
heart rate did not change between LO and HO. The slope (k) was higher in HO
considered as concentric remodeling than in LO as inadequate eccentric re-
modeling. These results suggest that change in LV geometry and functional
characteristics of myocardium could depend on the degree of blocking ac-
tion of local ATI!.
Edward Yellin, Steven Solomon, William Stevenson-Smith, Srdjan Nikolic. Albert
Einstein College of Medicine, The Bronx, NY
Thus, in this model of heart failure, chronic depression of contractility re-
quires constant use ofthe Frank-Starling mechanism to maintain cardiac out-
put, and the ventricle remodels by dilating (both Vm and Vo increased) as well
as by increasing compliance (Sp decreased), This growth pattern is adaptive,
although it may not allow regression. The exponential model failed to show
a change in stiffness. The logarithmic approach is both physiologically and
mathematically superior.
Ventricular remodeling is an important adaptation to both physiologic and
pathologic stress and is accompanied by changes in passive myocardial and
chamber properties. The analysis of remodeling and its subsequent effect
on the dynamics of both systolic and diastolic function, requires the use of
an appropriate mathematical characterization. We compared the exponen-
tial and logarithmic models in a study of ventricular dilatation following four
weeks of rapid ventricular pacing (240/min) in dogs. We start by rejecting the
relation, P = AekV , because it does not allow for a positive value of the equi-
librium volume, Yo, ie, the volume at zero transmural pressure, and we use:
P = Poo[ek<V-VO) - 1], so that stiffness is given by: dP/dV = kIP + Pool. Thus,
both k and Poo (the pressure asymptote) determine chamber stiffness. It is
important to note the mathematical limitations of an exponential: because
P00 is small and because the equation is asymptotic to the volume axis, there
is a strong tendency to underestimate Yo, often giving negative values when
using nonlinear regression analyses. These mathematical and physiological
problems are overcome by the logarithmic model: P = -Spln[(Vm - V)/(Vm
- Yo)]; dP/dV = Sp/(Vm - V), where Sp is a stiffness parameter in the posi-
tive plane, and Vm is the maximum physiologic volume that the ventricle can
tolerate. Yo, an important parameter in remodeling, is accurately determined
because the equation is not asymptotic to the volume axis. Furthermore, Sp
has the units of stress and thus characterizes the myocardium, and, when
normalized by the operating volume, Vm - Yo, the chamber.
CON-RV CON-LV DCM-RV DCM-LV
VELSHORT-BASE II-'m/s) 90± 5+ 50 ± 1 48 ± 2*+ 32 ± 1*
VELSHORT-,BAR II-'m/s) 206 ± 8+ 150± 5 123 ± 8* 111 ±9*
PERSHORT-BASE 1%) 5.8 ± 0.2+ 4.6 ± 0.1 3.1 ±0.1*+ 2.2 ± 0.1*
PERSHORT-,BAR 1%) 11.5 ± 0.3+ 10.2 ± 0.3 59 ± 0.3* 5.2 ± 0.4*
Length (I-'m) 150 ± 2+ 137 ± 1 179 ± 2*+ 173 ± 2*
CSA (I-'m2) 176 ± 4+ 362 ± 8 232 ± 4*+ 292 ± 5*
Mass Igm/kg) 0.8 ± 0.1+ 2.8 ± 0.1 1.6 ± 0.1*+ 2.9 ± 0.2
Right (RV) and Left Ventricular (LV) Geometry and
Myocyte Contractile Processes with Dilated
Cardiomyopathy (DCM): Disparity Between
Myocyte Growth and p-Adrenergic
Responsiveness
William S. McMahon, Paul C. Gillette, Fred A. Crawford, Francis G. Spinale. Med
Univ ofSouth Carolina, Charleston, SC
The progression of OCM has been assumed to be a homogenous process
for both the RV and LV However, this assumption has never been tested. Ac-
cordingly, we measured myocyte contractile performance (velocity of short-
ening, VELSHORT; percent shortening, PERSHORTI at baseline (BASE) and
after fJ-adrenergic receptor stimulation (fJAR, 25 nM isoproterenol) of iso-
lated myocytes taken from the RV and LV of 5 pigs with pacing induced
OCM (240 bpm, 3 weeks) and 5 control pigs (CON). RV and LV masslbody
weight (MASSI and myocyte length and cross-sectional area (CSA) were also
determined.
+p < 0.05 vs LV. *p < 005 vS CON
In controls, RV myocytes were longer and had a smaller CSA, but en-
hanced contractile performance at baseline and with fJ-adrenergic stimula-
tion. With OCM, no LV hypertrophy occurred. In contrast, RV chamber and
cellular hypertrophy occurred and was associated with a persistent increase
of RV myocyte baseline contractile function. Summary; This study demon-
strated, for the first time, that differences in RV and LV myocyte function and
fJ- adrenergic responsiveness exist in normal and OCM states. More impor-
tantly, a disparity in RV and LV myocyte growth with OCM occurred. Thus,
in this model of OCM, RV and LV growth and changes in contractile perfor-
mance are not a homogenous process, and suggest that inherent differences
exist in the response of RV and LV myocytes to stress.
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